Financial Performance - Total revenues for the three months ended April 30, 2025, were $759,043,000, representing a 16.7% increase from $650,345,000 in the same period of 2024[18]. - Subscription services revenue increased to $634,768,000, up 18.9% from $533,955,000 year-over-year[18]. - Net income for the quarter was $228,190,000, a 41.1% increase compared to $161,664,000 in the prior year[18]. - Operating income rose to $233,732,000, reflecting a 50.5% increase from $155,172,000 in the same quarter of 2024[18]. - The company reported a gross profit of $585,219,000, which is a 22.8% increase from $476,461,000 in the same quarter last year[18]. - Net cash provided by operating activities was $877,158,000, compared to $763,516,000 for the same period in 2024, marking a 14.9% increase[24]. - The company generated net income of $714 million for the fiscal year ended January 31, 2025, representing a 35.7% increase from $526 million in 2024[80]. Assets and Equity - Cash and cash equivalents at the end of the period were $1,964,982,000, up from $1,118,785,000 at the beginning of the year[15]. - Total assets increased to $7,765,077,000, compared to $7,339,756,000 as of January 31, 2025[15]. - Stockholders' equity grew to $6,211,098,000, up from $5,832,373,000 at the end of the previous quarter[15]. - Veeva's total available-for-sale securities amounted to $4,103,435 thousand as of April 30, 2025, with a gross unrealized gain of $31,083 thousand and unrealized losses of $2,050 thousand[32]. Expenses - Research and development expenses were $184,033,000, an increase of 13.1% from $162,711,000 in the prior year[18]. - Sales and marketing expenses increased slightly to $98,628 thousand, a 1% rise from $97,301 thousand, driven by higher employee compensation costs[107]. - General and administrative expenses increased by 12% to $68,826 thousand, primarily due to a $10 million rise in employee compensation-related costs[109]. Tax and Income Per Share - The effective tax rate for the three months ended April 30, 2025, was 23.6%, up from 21.9% in the prior year, primarily due to reduced future benefits from non-deductible compensation[44]. - Basic net income per share increased to $1.40 for the three months ended April 30, 2025, up from $1.00 in the same period of 2024, a 40% increase[60]. Customer and Market Insights - North America generated $459,467 thousand in revenues for the three months ended April 30, 2025, a 20.4% increase from $381,599 thousand in 2024[71]. - R&D Solutions accounted for 54% of total revenues for the three months ended April 30, 2025, while Commercial Solutions accounted for 46%[79]. - The company served 1,477 customers as of January 31, 2025, an increase from 1,432 customers in 2024[81]. Risks and Challenges - The company faces risks related to cybersecurity, including potential breaches that could harm customer trust and lead to significant liabilities[153]. - The markets for the company's solutions are highly competitive, with significant competition from firms like Salesforce and IQVIA[160]. - The company is subject to changing laws and regulations, which may impose additional compliance costs and liabilities[158]. - The company faces risks related to international operations, including regulatory, economic, and political challenges[171]. Compliance and Regulatory Environment - Compliance with complex regulations in the life sciences industry is essential; failure to comply could lessen demand for solutions and expose the company to significant claims[193]. - Increasingly complex data protection regulations, such as the EU GDPR, impose significant obligations and potential penalties for non-compliance, affecting operational costs[199]. - The company anticipates ongoing evolution of privacy and data protection laws, which will require continuous compliance efforts and could lead to increased operational complexity[201]. Strategic Initiatives - The company announced the launch of Veeva AI, integrating AI across major application areas, which may introduce new risks and challenges affecting adoption[207]. - The company expects R&D Solutions revenues to increase as a percentage of total revenues in the future[79].

Group 1 - The article discusses Veeva (NYSE: VEEV) and reiterates a "buy" rating for 2025 with a price target of $286 per share [1] - The author emphasizes the importance of investing in sustainable, growth-driven companies that maximize shareholder equity [1] - The article highlights the author's background in high-growth supply-chain start-ups and experience with venture capital firms, which contributed to maximizing returns for clients during the pandemic [1] Group 2 - The author has a beneficial long position in VEEV shares through stock ownership, options, or other derivatives [2] - The article expresses the author's personal opinions and does not involve compensation from any company mentioned [2] - Seeking Alpha clarifies that past performance is not indicative of future results and that the views expressed may not reflect those of the platform as a whole [3]

Veeva Systems Inc. VEEV posted better-than-expected earnings for the first quarter and raised the outlook on Wednesday.The company reported adjusted earnings per share of $1.97, beating the analyst consensus estimate of $1.77. Quarterly sales of $759 million (+17% year over year) outpaced the Street view of $731.91 million."We crossed our 2025 revenue run rate goal this quarter and are progressing well toward our 2030 goal to double that and the positive impact we can have for our customers and the industry ...

Veeva Systems, Inc. (VEEV) reported adjusted earnings per share (EPS) of $1.97 for the first quarter of fiscal 2026, which increased 31.3% from the year-ago figure of $1.50. Adjusted EPS surpassed the Zacks Consensus Estimate by 13.22%. (Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.)GAAP EPS in the fiscal first quarter was $1.37, up 39.8% from the year-ago period’s 98 cents.VEEV’s Revenue DetailsIn the quarter under review, the company’s revenues totaled $759 million, outpacing t ...

CHONGQING, CHINA - MAY 25: In this photo illustration, the logo of Veeva Systems Inc. is displayed ... More on a smartphone screen, with the latest stock market chart of the company in the background, reflecting investor sentiment and recent trading activity, on May 25, 2025, in Chongqing, China. (Photo Illustration by Cheng Xin/Getty Images)Getty Images Veeva Systems (NYSE: VEEV) stock, a cloud-based software firm, surged 16% in after-hours trading on May 28, following a strong performance in Q1 fiscal yea ...

Core Insights - Veeva Systems reported revenue of $759.04 million for the quarter ended April 2025, reflecting a year-over-year increase of 16.7% and surpassing the Zacks Consensus Estimate by 4.27% [1] - The company's EPS for the quarter was $1.97, up from $1.50 in the same quarter last year, resulting in an EPS surprise of 13.22% compared to the consensus estimate of $1.74 [1] Financial Performance Metrics - Non-GAAP Gross Margin for Professional Services and other was reported at 33.6%, exceeding the average estimate of 26.6% by nine analysts [4] - Non-GAAP Gross Margin for Subscription services was 88.1%, higher than the estimated 86% by nine analysts [4] - Subscription services revenue reached $634.77 million, surpassing the average estimate of $615.93 million and showing an 18.9% year-over-year increase [4] - Professional services and other revenue was $124.28 million, exceeding the average estimate of $112.07 million, with a year-over-year change of 6.8% [4] - Veeva R&D Solutions generated $77.71 million in revenue, compared to the estimated $64.87 million, marking a 14.9% increase year-over-year [4] - Subscription services revenue from Veeva R&D Solutions was $329.36 million, slightly above the estimate of $328.16 million, reflecting a 20.8% year-over-year increase [4] - Subscription services revenue from Veeva Commercial Solutions was $305.41 million, exceeding the average estimate of $287.80 million, with a year-over-year change of 16.9% [4] - Professional services and other revenue from Veeva Commercial Solutions was $46.57 million, slightly below the average estimate of $46.98 million, showing a year-over-year decline of 4.5% [4] Stock Performance - Veeva's shares have returned +2.8% over the past month, while the Zacks S&P 500 composite has increased by +7.4% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Veeva Systems (VEEV) came out with quarterly earnings of $1.97 per share, beating the Zacks Consensus Estimate of $1.74 per share. This compares to earnings of $1.50 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 13.22%. A quarter ago, it was expected that this provider of cloud-based software services for the life sciences industry would post earnings of $1.58 per share when it actually produced earnings of $1.74, deliverin ...

Financial Data and Key Metrics Changes - Total revenue for Q1 2026 was $759 million, with a non-GAAP operating margin of 46%, exceeding guidance [7] - The company achieved a revenue run rate goal of $3 billion for calendar year 2025 [7] Business Line Data and Key Metrics Changes - Vault CRM is performing well, with over 80 customers live, and the expectation to reach about 200 customers live in the next year [12][13] - Crossix is highlighted as a significant growth driver, with strong performance in marketing and optimization, growing over 30% year-over-year [32][43] Market Data and Key Metrics Changes - The macro environment is described as more uncertain compared to the previous quarter, but no material changes in financial results or pipeline have been observed [7][17] - The company is seeing strong growth in its R&D business, with guidance for the year set at 19% [32] Company Strategy and Development Direction - The company is focusing on horizontal CRM applications, with plans to have first customers by the end of the year [22][25] - The AI initiative, Veeva.ai, is expected to significantly enhance efficiency in the life sciences industry, with a target of increasing efficiency by 15% over the next few years [58][60] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the uncertainty in the macro environment but emphasizes that the business remains insulated due to long-term subscription contracts [68][85] - There is optimism regarding the integration of AI into core applications, which is expected to provide substantial value to customers [60][88] Other Important Information - The company is committed to maintaining a disciplined approach to acquisitions, focusing on synergistic opportunities in horizontal applications [121] - The recent Commercial Summit indicated strong customer sentiment and excitement around new product offerings, particularly in CRM and AI [91][96] Q&A Session Summary Question: Customer migration to Vault CRM - Management noted that the migration to Vault CRM is driven by its superior capabilities compared to Veeva CRM, with a mix of new customers and migrations contributing to growth [12][14] Question: Impact of macroeconomic factors on revenue - Management stated that while there is uncertainty in the macro environment, it has not yet impacted financial results or pipeline, with ongoing projects proceeding as expected [17][70] Question: Horizontal CRM strategy - The company is excited about the potential of horizontal CRM applications, with plans to identify customer segments and product areas [22][25] Question: Drivers of Crossix's growth - Crossix's growth is attributed to its expanded product offerings and the increasing demand for digital marketing effectiveness among clients [32][43] Question: AI integration and customer feedback - Initial customer feedback on Veeva.ai has been positive, with expectations that it will enhance operational efficiency and provide significant value [88][96] Question: CRM conversion pace among top pharma companies - Management indicated that progress with top 20 pharma companies is on track, with no urgency to migrate as customers are satisfied with existing solutions [107][109] Question: Customer focus on ROI and budget priorities - There is a noted increase in focus on digital marketing and analytics among pharma executives, reflecting a systematic approach to commercial strategies [111]

Financial Data and Key Metrics Changes - Total revenue for the quarter was $759 million, with a non-GAAP operating margin of 46%, marking a strong start to the year and exceeding guidance [9][10] - The company achieved its calendar 2025 revenue run rate goal of $3 billion [9] Business Line Data and Key Metrics Changes - The Vault CRM is performing well, with over 80 customers live, and the company expects to reach about 200 customers live on Vault CRM within a year [13][14] - Crossix has shown strong growth, with a year-over-year growth rate exceeding 30%, driven by usage-based areas of the business [32][42] Market Data and Key Metrics Changes - The macro environment remains uncertain, but there has been no material change in financial results or pipeline at this time [9][18] - The company is seeing strong demand for its digital marketing capabilities, particularly in the Crossix segment, which is gaining market share [40][42] Company Strategy and Development Direction - The company is focusing on horizontal CRM applications, with plans to have first customers by the end of the year [22][24] - Veeva is committed to integrating AI deeply into its core applications, aiming to enhance efficiency in the life sciences industry by approximately 15% over the next few years [58][60] Management's Comments on Operating Environment and Future Outlook - Management acknowledges increased uncertainty in the macro environment but has not seen a significant impact on business operations or customer pipelines [68][70] - The company remains optimistic about its subscription-based business model, which is less susceptible to short-term market fluctuations [88][90] Other Important Information - The company is excited about the potential of Veeva.ai, which aims to provide significant value to customers by automating various tasks [100][101] - The recent Commercial Summit highlighted positive customer sentiment and the growing maturity of the Vault CRM product [96][98] Q&A Session Summary Question: Customer migration to Vault CRM - Management noted that the number of customers migrating to Vault CRM has increased, with reasons for migration including better product features and AI integration [12][14] Question: Impact of macroeconomic factors on revenue - Management indicated that while there is uncertainty in the macro environment, it has not yet affected financial results or pipeline [17][70] Question: Horizontal CRM strategy - The company is excited about the horizontal CRM market and is focusing on customer success and product excellence [22][24] Question: Drivers of growth in Crossix - Crossix's growth is attributed to an expanded product offering and a strategic approach to customer engagement [40][42] Question: AI integration in life sciences - Management expressed confidence in the potential of AI to enhance operational efficiency and provide significant value to customers [58][60] Question: Customer feedback on new products - Initial feedback from customers regarding new products, including Veeva.ai, has been positive, indicating a strong demand for integrated solutions [90][100]

Q1'26 Quarterly Results May 28, 2025 Safe Harbor and Other Information This presentation and associated commentary contain forward-looking statements regarding Veeva's expected future performance and, in particular, includes guidance, provided as of May 28, 2025, about Veeva's expected future financial results. Estimating guidance accurately for future periods is difficult. It involves assumptions and internal estimates that may prove to be incorrect and is based on plans that may change. Hence, there is a ...